why biotechs need to worry about generics, too, page-9

should of been Lawyers...

Gabbie i now have a better understanding from this site

http://www.buildingipvalue.com/n_us/154_157.htm

Once the pharma gets the life extension from our product the on going value added from the enhanced product with the built in safety features will differentiate the original from the generic...they will be locked in to our device.